Suzanne learned she had glaucoma during an eye check-up when she was 65. Now, for the past five years, she has been receiving treatment to protect her eyes from further damage.
Leaving a gift in your Will is a spark of generosity that will continue beyond our lifetime. It allows us to invest in the research that will one day find a cure and continue to support families impacted by glaucoma.
AI is set to revolutionise the way doctors and patients interact with ophthalmic healthcare, with several published diagnostic AI models already boasting performance on par with eye specialists in the detection of diabetic retinopathy, macular degeneration, and glaucoma.
Macquarie University researchers have identified a gene therapy that could help treat glaucoma, with potential applications for other neurodegenerative conditions such as Alzheimer’s disease.
Researchers at University College London (UCL) and Moorfields Eye Hospital have found blood markers that can predict if glaucoma patients are likely to keep losing vision even after treatment.
Patricia discovered she inherited glaucoma from her father after developing cataracts. She underwent a successful surgery and is now taking eye drops regularly. She now advises others to get tested early.
Research suggests a large language model (LLM) artificial intelligence (AI) system can match, or sometimes do better than, human eye doctors in diagnosing and treating patients with glaucoma and retina disease.
Annette was diagnosed with Normal Tension Glaucoma a few years ago, and despite the challenges of managing eye pressure and a pituitary cyst, her proactive approach with treatments and family awareness gives her hope for a stable future.
Kenneth's glaucoma journey started with headaches from his teens until age 48 when family history prompted testing, revealing high eye pressure.